Published On: Wed, Apr 22nd, 2015

Perrigo rejects Mylan’s $29 billion takeover bid

The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.

Joseph C. Papa - PERRIGO - PR


The board of directors of Perrigo Company (NYSE:PRGO; TASE:PRGO) has unanimously rejected the offer by Mylan NV to buy all its shares for $29 billion. Two weeks after receiving the offer, the pharmaceutical company told the NYSE last night that it felt the offer made by Mylan at a 25% premium of its share price, does not reflect the true value of the company, and does not serve the shareholders’ interests…



GLOBES logo-eng (1)Published by Globes [online], Israel business news –



Read more about: , , , , , , , , , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems